Skip to main content

Most Popular

VITAL Study - Autoimmune Prevention Requires Continued Supplements

Feb 07, 2024

In the 2 years that followed the termination of the VITAL study, the preventative effect of vitamin D on incident autoimmune disease disappeared with supplement discontinuation; but n-3 fatty acid treated individuals had a sustained benefit in reducing the risk of autoimmune disease.

Read Article

Eating for Rheumatoid Arthritis

Feb 21, 2024

The majority of practicing rheumatologists at RheumNow Live were unaware of the new ACR guidelines issued in 2022 regarding dietary and lifestyle recommendations for patients with Rheumatoid Arthritis (RA) (1).  Dr.

Read Article

Cochrane Review: How Good is Ultrasound Diagnosing GCA?

Feb 19, 2024

Is temporal artery ultrasound (US) equivalent or superior to the reference standard of temporal artery biopsy (TAB) when diagnosing giant cell arteritis (GCA)?

Read Article

One-Third of Physicians Intend to Leave Academia

Jan 31, 2024

A cross-sectional survey of academic physicians shows that approximately one-third intend to leave their institutions in the next two years. Burnout, lack of professional fulfillment, and other personal and organizational factors were associated with intention to leave.

Read Article

Determinants of Gout Flares

Feb 06, 2024

Approximately 12 million US adults in the US have gout. Two recent literature reports highlight contributors to gout flares.

Read Article

Top 5 Clinical Pearls in RA Management

Feb 15, 2024

RheumNow Live 2024 provided a wealth of clinical insights, particularly in the realm of rheumatoid arthritis (RA) management. Here are the top five clinical pearls from the event's opening session, "Success in Rheumatoid Arthritis."

Read Article

How do you manage enthesitis?

Feb 16, 2024

Enthesitis can be a challenge for clinicians to identify, evaluate, and manage in patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA). It affects 27-35% of PsA patients and 36% of axSpA patients. Dr.

Read Article

CD19 CAR T-Cell Therapy in Autoimmune Disease

Feb 22, 2024

The NEJM has published the results of CD19 B cell depletion (by CAR-T cell therapy) in autoimmune disease patients, demonstrating it to be feasible, safe, and efficacious.

Read Article

SeXXist Reason for More Women with Autoimmune Disease

EurekAlert!
Feb 01, 2024

Somewhere between 24 and 50 million Americans have an autoimmune disease, a condition in which the immune system attacks our own tissues. As many as 4 out of 5 of those people are women.

Read Article

APIPPRA Trial: Abatacept in at-risk rheumatoid arthritis patients

Feb 15, 2024

Abatacept has been studied in seropositive clinically suspect arthralgia patients (at risk for rheumatoid arthritis) and shows the potential to delay or prevent the disease. 

Read Article

Diet and Osteoarthritis Pain

MedPage Today
Jan 29, 2024

Knee osteoarthritis (OA) pain was worse with a pro-inflammatory diet, an observational study suggested.

Read Article

Vasculitis Pearls

Once again RheumNow Live 2024 really delivered with high impact learning packed into short sessions. As someone with an interest in vasculitis it was fantastic to see four of my favorite speakers in the Vasculitis Mavens and STEP talks.

Read Article

Co-management of Psoriatic Disease

It is a common clinical scenario to see someone with both severe psoriatic arthritis and skin psoriasis. Co-management with dermatology optimises the care of this patient group.

Read Article

Inflammatory Arthritis in Systemic Sclerosis is Problematic

Feb 08, 2024

Inflammatory arthritis (IA) is a common manifestation in systemic sclerosis (SSc), affecting nearly one-third of patients.

Read Article

Behçet’s Syndrome

Feb 26, 2024

A comprehensive overview of Behcet's syndrome appeared in last week's NEJM, reviewing the numerous advances in the immunogenetics, syndrome recognition, and targeted therapeutic approaches.

Read Article

Oral IL-23 Inhibitor Effective in Psoriasis

Feb 09, 2024

The NEJM has published the results of the FRONTIER 1 trial demonstrating the efficacy of JNJ-77242113, an oral interleukin-23 (IL-23) receptor antagonist peptide, in patients with psoriasis (PSO). 

Read Article

What are the Early Stages of Lupus?

Feb 14, 2024

Incomplete lupus? Undifferentiated connective tissue disease? Pre-clinical autoimmune disease?

Read Article

ARIAA Trial: Abatacept Delays the Onset of RA

Feb 20, 2024

The ARIAA trial tested the utility of IV abatacept in individuals ACPA+ arthralgia patients with subclinical inflammation and showed abatacept to decrease MRI inflammation, clinical symptoms, and risk of future rheumatoid arthritis (RA) development.

Read Article

Leaving Academia (2.2.24)

Feb 01, 2024

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. This week we discuss hipsters undergoing hip replacement, pregnancy outcomes in RA and the future of academic clinicians.

Read Article